Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis
{{output}}
In recent years, the role of interleukin-17 (IL-17) in orchestrating and manipulating proinflammatory immune responses has received special attention. It has become apparent from murine studies and clinical trials that due to its inhibitory effect on immunoreg... ...